top of page
Elucid Secures $8 Million in Series A Funding Led by MedTex Ventures and Global Health Impact Fund
BOSTON--(BUSINESS WIRE)--Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today...
QSAM Biosciences Closes Series B Preferred Private Placement led by Checkmate Capital.
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing...
Press
bottom of page